Triangle CROs see opportunity, challenges in push for diversity in clinical trials


The FDA's push to improve diversity among clinical trial participants could create new opportunities for Triangle contract research organizations.

Previous After $40M funding win, USF wants to position itself on a national stage with center for nursing
Next Bonnie Brae Tavern closing after 88 years, sold to developers